These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31696968)

  • 1. Synthesis, biological screening, and molecular docking of quinazolinone and quinazolinethione as phosphodiesterase 7 inhibitors.
    Elfeky SM; Sobahi TR; Gineinah MM; Ahmed NS
    Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900211. PubMed ID: 31696968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinazolinones, Quinazolinthiones, and Quinazolinimines as Nitric Oxide Synthase Inhibitors: Synthetic Study and Biological Evaluation.
    Camacho ME; Chayah M; García ME; Fernández-Sáez N; Arias F; Gallo MA; Carrión MD
    Arch Pharm (Weinheim); 2016 Aug; 349(8):638-50. PubMed ID: 27328401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors.
    Sánchez AI; Martínez-Barrasa V; Burgos C; Vaquero JJ; Alvarez-Builla J; Terricabras E; Segarra V
    Bioorg Med Chem; 2013 Apr; 21(8):2370-2378. PubMed ID: 23454131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of some novel quinazolin-4(3H)-one hybrid molecules as potent urease inhibitors.
    Menteşe E; Akyüz G; Yılmaz F; Baltaş N; Emirik M
    Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800182. PubMed ID: 30375666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer's disease.
    Haghighijoo Z; Firuzi O; Hemmateenejad B; Emami S; Edraki N; Miri R
    Bioorg Chem; 2017 Oct; 74():126-133. PubMed ID: 28780149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
    Abdel-Rahman HM; Abdel-Aziz M; Canzoneri JC; Gary BD; Piazza GA
    Arch Pharm (Weinheim); 2014 Sep; 347(9):650-7. PubMed ID: 24985336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA.
    Hrast M; Rožman K; Jukič M; Patin D; Gobec S; Sova M
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3529-3533. PubMed ID: 28579123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and docking studies of bischalcones based quinazoline-2(1H)-ones and quinazoline-2(1H)-thiones derivatives as novel inhibitors of cathepsin B and cathepsin H.
    Raghav N; Singh M
    Eur J Pharm Sci; 2014 Apr; 54():28-39. PubMed ID: 24412851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structural analysis, and biological evaluation of thioxoquinazoline derivatives as phosphodiesterase 7 inhibitors.
    Castaño T; Wang H; Campillo NE; Ballester S; González-García C; Hernández J; Pérez C; Cuenca J; Pérez-Castillo A; Martínez A; Huertas O; Gelpí JL; Luque FJ; Ke H; Gil C
    ChemMedChem; 2009 May; 4(5):866-76. PubMed ID: 19350606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinazoline-4(3H)-one derivatives as novel and potent inhibitors of soluble epoxide hydrolase: Design, synthesis and biological evaluation.
    Hejazi L; Rezaee E; Tabatabai SA
    Bioorg Chem; 2020 Jun; 99():103736. PubMed ID: 32229350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Design, synthesis and biological evaluation of novel para-substituted 1-benzyl-quinazoline-2, 4 (1H, 3H)-diones as human PARP-1 inhibitors].
    Yao HP; Zhu ZX; Ji M; Chen XG; Xu BL
    Yao Xue Xue Bao; 2014 Apr; 49(4):497-503. PubMed ID: 24974467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro urease inhibition and molecular docking studies of some novel quinazolin-4(3H)-one derivatives containing triazole, thiadiazole and thiosemicarbazide functionalities.
    Menteşe E; Akyüz G; Emirik M; Baltaş N
    Bioorg Chem; 2019 Mar; 83():289-296. PubMed ID: 30391701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues.
    El-Azab AS; Abdel-Aziz AA; Ghabbour HA; Al-Gendy MA
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1229-1239. PubMed ID: 28948843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
    Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
    J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of α-glucosidase inhibitors by room temperature C-C cross couplings of quinazolinones.
    Garlapati R; Pottabathini N; Gurram V; Kasani KS; Gundla R; Thulluri C; Machiraju PK; Chaudhary AB; Addepally U; Dayam R; Chunduri VR; Patro B
    Org Biomol Chem; 2013 Aug; 11(29):4778-91. PubMed ID: 23778751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel anilide and benzylamide derivatives of arylpiperazinylalkanoic acids as 5-HT
    Jankowska A; Satała G; Kołaczkowski M; Bucki A; Głuch-Lutwin M; Świerczek A; Pociecha K; Partyka A; Jastrzębska-Więsek M; Lubelska A; Latacz G; Gawalska A; Bojarski AJ; Wyska E; Chłoń-Rzepa G
    Eur J Med Chem; 2020 Sep; 201():112437. PubMed ID: 32673902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship studies of dihydronaphthyridinediones as a novel structural class of potent and selective PDE7 inhibitors.
    Gewald R; Rueger C; Grunwald C; Egerland U; Hoefgen N
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6652-6. PubMed ID: 21983442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, molecular docking, and some metabolic enzyme inhibition properties of novel quinazolinone derivatives.
    Tokalı FS; Taslimi P; Demircioğlu İH; Karaman M; Gültekin MS; Şendil K; Gülçin İ
    Arch Pharm (Weinheim); 2021 May; 354(5):e2000455. PubMed ID: 33537994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling phosphodiesterase surfaces. Identification of phosphodiesterase 7 allosteric modulation cavities.
    Redondo M; Soteras I; Brea J; González-García A; Cadavid MI; Loza MI; Martinez A; Gil C; Campillo NE
    Eur J Med Chem; 2013; 70():781-8. PubMed ID: 24239625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.